ClinicalTrials.gg
Enrolling by invitationNCT06633263Updated Nov 1, 2024

Combined Effect of TCC-I and BATD on Depressive Symptoms and Insomnia

An interventional study of Cognitive Behavioral Therapy for Insomnia and Behavioral Activation Treatment for Depression in Depression - Major Depressive Disorder and Insomnia, sponsored by University of Liege. Enrolling by invitation at 1 site in Belgium. Open to participants aged 18 Years to 67 Years. Per ClinicalTrials.gov, last updated 2024-11-01.

Sponsored by University of Liege · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Non-randomized
Ages
18 Years to 67 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 31 studies in Sleep Initiation and Maintenance Disorders with a site in Belgium — 11 open to participants now, 13 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Belgium.

Planned enrollment
25th of 26
12 · median 124
Started
2024
with 1 other
No phase
18 of 31
8 open now
Primary completion
2027-06
later than 9 of 12 live
Registered
21st of 31
by date

Among the 31 studies in Sleep Initiation and Maintenance Disorders with a site in Belgium, this one is the 25th largest by planned enrollment of the 26 interventional ones that give a count, is one of 2 that started in 2024, is one of 18 with no phase, reaches primary completion later than 9 of the 12 other live ones, and was the 21st registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

11 of the 31 studies in Sleep Initiation and Maintenance Disorders with a site in Belgium are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 18 Years to 67 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 31 studies in Sleep Initiation and Maintenance Disorders with a site in Belgium, or all of them as a file.
02

Study summary

The goals of this interventional study is to study if the combine effects of Behavioral Activation Treatment for Depression (BATD) and Cognitive Behavioral Therapy for Insomnia (CBT-I) is effective on primary outcomes : depression, insomnia, well-being and anxiety and secondary outcomes : worry, rumination, behavioral inertia, experiential avoidance, anticipatory pleasure deficits, cognitive resource deficits, emotional reactivity, quality of sleep, and sleep beliefs for participants suffering from depression and insomnia disorders.

Read the detailed description

Depression is a widespread mental disorder characterized by affective, cognitive and physiological disturbances that impact individuals' daily functioning. Sleep difficulties are an essential component of the clinical picture of depression. Several interventional studies have demonstrated the value of specific insomnia treatment in the management of depression. Indeed, the absence of targeted treatment for insomnia increases the risk of depressive relapse. In this context, the importance of specific treatment of insomnia in cases of comorbidity with depression, and the need to integrate this approach into clinical practice, have recently been highlighted. However, very few studies have explored the efficacy of combined treatment of insomnia (with Cognitive Behavioural Therapy for Insomnia - CBT-I) and depression (with Behavioural Activation Treatment for Depression - BATD). However, one study has shown that BATD can have beneficial effects on sleep quality (in caregivers of people with Alzheimer's disease). The combined treatment of CBT-I and BATD, as well as the importance of the order of administration of these interventions in cases of insomnia-depression comorbidity, however, remain unexplored.

The aim of this study is to evaluate the overall effect of the combination of CBT-I and a BATD on depressive symptoms and insomnia in the short, medium and long term. It also seeks to examine the specific effects of each intervention. In addition, the study assesses efficacy and adherence under two different orders of treatment combination, while exploring the psychological mechanisms likely to promote positive symptoms change. Finally, it looks at inter-individual differences in responses to interventions. Our study will help provide empirical evidence on the efficacy of combined treatment for people suffering from insomnia and depression. By identifying the psychological mechanisms that may promote improvement in these comorbid disorders, it could also help refine and improve current treatments.

Participants will be recruited through a number of sources, including the CPLU (Clinique Psychologique et Logopédique de l Université de Liège), word of mouth, announcements within the University (e.g. via the student and staff quality of life service), social networks, and various CHU departments. A flyer will be distributed by clinicians and on social networks, including Facebook. Participants will also be identified through CHU psychologists, doctors and psychiatrists, who have potential access to the target population (people suffering from sleep disorders and depression).

An initial telephone interview will take place to check the inclusion and exclusion criteria, explain how the study works and the various appointment dates.

Participants wishing to take part in the study, but presenting exclusion criteria, will be redirected to appropriate care services according to their difficulties. This may include services specializing in sleep disorders, services dedicated to the management of psychological disorders, psychiatric emergencies in the event of significant suicidal ideation, or individual psychological follow-up by a specialized therapist (such as primary care psychologists or CBT psychotherapists).

If the person meets the criteria, an initial interview will be arranged. During this first clinical interview, the protocol will be presented in greater detail. Participants' expectations and motivations will be investigated to ensure that the proposed intervention can meet them. The information letter and informed consents will be offered to the participant. A socio-demographic questionnaire will be proposed. The content of the assessments to be completed daily will be presented to the participants. At the end of this interview, they will also be invited to complete the standardized pre-intervention questionnaires.

Participants will then begin self-observation for two weeks, before starting the first intervention (CBT-I in condition 1 and BATD in condition 2). This will be followed by a further two-week period of observation without intervention, prior to the second intervention (BATD in condition 1 and CBT-I in condition 2). A final two-week self-observation phase follows the second intervention.

03

Conditions studied

  • Depression - Major Depressive Disorder
  • Insomnia

Keywords

  • depression
  • insomnia
  • CBT-I
  • BATD
  • combined intervention
  • multiple case study
  • Single Case Experimental Design
04

Who can participate

Ages eligible
18 Years to 67 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants will be adults with depression (PhQ 9 > 10; cut-off for moderate depression) and insomnia (Insomnia Severity Index > 11) who also meet criteria for depression and insomnia (APA, 2013) and have a good understanding of French.

Exclusion criteria

Exclusion Criteria:

  • Participants requiring different treatment, i.e. those with symptoms suggestive of psychotic disorder, bipolar disorder, substance abuse disorder, excessive suicidal ideation, or other sleep pathology (such as sleep apnea, restless legs syndrome, narcolepsy, sleepwalking, or periodic limb movements)
  • Participants who have recently received or are currently receiving other interventions that could be confused with our intervention, such as those undergoing treatment for sleep or depression, or those undergoing parallel psychological or pharmacological treatment (antidepressants and anxiolytics will be accepted provided they have been stabilized for at least two months and there are no planned changes in the following weeks).
  • Participants with commitments that disrupt nocturnal sleep cycles and habits, such as those who no longer work or who work night shifts, will also be excluded from the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    CBT-I followed by BATD

    1. Five group CBT-I sessions of two hours, one per week. 2. Two-week break - baseline 3. Five individual BATD sessions of one hour, one per week. Because of the diverse content of ruminations and avoidances in depression (Blairy et al., 2020), AC therapy will be administered in an individual format, while CBT-I will take place in a group setting.

    Behavioral: Cognitive Behavioral Therapy for Insomnia · Behavioral: Behavioral Activation Treatment for Depression

  • Experimental
    BATD followed by CBT-I

    1. Five individual BATD sessions of one hour, one per week. Because of the diverse content of ruminations and avoidances in depression (Blairy et al., 2020), AC therapy will be administered in an individual format, while CBT-I will take place in a group setting. 2. Two-week break - baseline 3. Five group CBT-I sessions of two hours, one per week.

    Behavioral: Cognitive Behavioral Therapy for Insomnia · Behavioral: Behavioral Activation Treatment for Depression

Interventions

  • BehavioralCognitive Behavioral Therapy for Insomnia

    Introduce self-recording with the sleep diary; Introduce basic notions of insomnia; Introduce basic notions of sleep hygiene; Introduce basic notions of sleep; Recreate a time and place dedicated to sleep; Limit time spent in bed to time slept; Promote attitudes and beliefs that favor sleep and manage worries; Relapse prevention. This intervention is empirically validated (Morin, 2022).

  • BehavioralBehavioral Activation Treatment for Depression

    Introduce self-recording with daily activities; Introduce the basic concept of depression; Identify and increase activities associated with positive reinforcement; Reflect on life domains and values to identify reinforcing activities; Identify and decrease activities associated with negative reinforcement; Identify and decrease activities associated with negative reinforcement; Relapse prevention. This intervention is empirically validated (Ciharova et al., 2021)

06

What researchers measure

Primary outcomes

  1. Anxiety

    Generalised Anxiety Disorder Questionnaire. Scores ranges from 0 to 21. Higher scores means worse outcome (higher anxiety symptoms)

    Time frame: Six measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention, three months after the second intervention, six months after the second intervention, and two years after

  2. Depression

    Patient Health Questionnaire. Scores ranges from 0 to 27. Higher scores means worse outcome (higher depressive symptoms)

    Time frame: Six measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention, three months after the second intervention, six months after the second intervention, and two years after

  3. Insomnia

    Insomnia Severity Index. Scores ranges from 0 to 28. Higher scores means worse outcome (higher insomnia)

    Time frame: Six measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention, three months after the second intervention, six months after the second intervention, and two years after

  4. Fatigue

    Multidimensional Fatigue Inventory - General and physical fatigue. Scores ranges from 9 to 45. Higher scores means worse outcome (higher general and physical fatigue).

    Time frame: Six measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention, three months after the second intervention, six months after the second intervention, and two years after

  5. Well-being

    Well-being - Warwick-Edinburgh Mental Wellbeing Scale. Scores ranges from 14 to 70. Higher scores means better outcome (higher well-being)

    Time frame: Six measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention, three months after the second intervention, six months after the second intervention, and two years after

  6. Socio-démographic Questionnaires

    Age, gender, socio-economical status, situation at home

    Time frame: Up to two weeks before the intervention

Secondary outcomes

  1. Sleep Beliefs

    Dysfunctional Beliefs and Attitudes about Sleep Scale. Scores ranges from 0 to 160. Higher scores means worse outcome (higher dysfunctional beliefs)

    Time frame: Six measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention, three months after the second intervention, six months after the second intervention, and two years after

  2. Client satisfaction

    Consumer Satisfaction Questionnaire. Scores ranges from 8 to 32. Higher scores means better outcome (higher satisfaction)

    Time frame: Two measures. up to two weeks after the first intervention, up to two weeks after the second intervention,

  3. Activation

    Activation level was collected daily at the end of the day in a booklet with the following item -I have been an active person and have accomplished the goals I set for myself- accompanied by a visual Analogue Scale (ranging from left side : not at all to right side completely). Scores ranges from 0 to 10. Higher scores means better outcome (higher behavioral activation)

    Time frame: Everyday through intervention completion (from week 1 up to 16 weeks later)

  4. Rumination

    Rumination level was collected daily at the end of the day in a booklet with the following item -I spent a lot of time dwelling on my problems- accompanied by a visual Analogue Scale (ranging from left side : not at all to right side completely). Scores ranges from 0 to 10. Higher scores means worse outcome (higher rumination)

    Time frame: Everyday through intervention completion (from week 1 up to 16 weeks later)

  5. Anticipatory pleasure

    Anticipatory pleasure level was collected daily at the end of the day in a booklet with the following item -I m looking forward to some upcoming events or activities- accompanied by a visual Analogue Scale (ranging from left side : not at all to right side completely). Scores ranges from 0 to 10. Higher scores means better outcome (higher anticipatory pleasure)

    Time frame: Everyday through intervention completion (from week 1 up to 16 weeks later)

  6. Avoidance

    Avoidance level was collected daily at the end of the day in a booklet with the following item -Most of the things I did were aimed at escaping or avoiding something unpleasant.- accompanied by a visual Analogue Scale (ranging from left side : not at all to right side completely). Scores ranges from 0 to 10. Higher scores means worse outcome (higher avoidance)

    Time frame: Everyday through intervention completion (from week 1 up to 16 weeks later)

  7. Worry

    Worry level was collected daily at the end of the day in a booklet with the following item -I worry about everything all the time- accompanied by a visual Analogue Scale (ranging from left side : not at all to right side completely). Scores ranges from 0 to 10. Higher scores means worse outcome (higher worry)

    Time frame: Everyday through intervention completion (from week 1 up to 16 weeks later)

  8. Emotional reactivity

    Emotional Reactivity level was collected daily at the end of the day in a booklet with the following item -I have found it difficult to cope emotionally with stressful situations or events that others might consider unimportant- accompanied by a visual Analogue Scale (ranging from left side : not at all to right side completely). Scores ranges from 0 to 10. Higher scores means worse outcome (higher emotional reactivity)

    Time frame: Everyday through intervention completion (from week 1 up to 16 weeks later)

  9. Emotional reactivity 2

    Emotional Reactivity 2 level was collected daily at the end of the day in a booklet with the following item -I have a tendency to react strongly, emotionally, to stressful situations or events that could have a negative impact on my sleep- accompanied by a visual Analogue Scale (ranging from left side : not at all to right side completely). Scores ranges from 0 to 10. Higher scores means worse outcome (higher emotional reactivity)

    Time frame: Everyday through intervention completion (from week 1 up to 16 weeks later)

  10. Cognitive ressources - Focusing

    Cognitive ressources level was collected daily at the end of the day in a booklet with the following item -It was easy for me to concentrate on a difficult task, even when there was noise all around- accompanied by a visual Analogue Scale (ranging from left side : not at all to right side completely). Scores ranges from 0 to 10. Higher scores means better outcome (better attentional focusing).

    Time frame: Everyday through intervention completion (from week 1 up to 16 weeks later)

  11. Cognitive ressources - Flexibility

    Cognitive ressources level was collected daily at the end of the day in a booklet with the following item -It was easy for me to alternate between two different tasks- accompanied by a visual Analogue Scale (ranging from left side : not at all to right side completely). Scores ranges from 0 to 10. Higher scores means better outcome (better attentional flexibility)

    Time frame: Everyday through intervention completion (from week 1 up to 16 weeks later)

  12. Sleep quality

    Sleep quality (Sleep onset latency, Total sleep Time, Wake after sleep onset, sleep efficiency) was collected daily via a sleep diary. Higher sleep onset latency and higher wake after sleep onset scores means a worse outcome, higher total sleep time and sleep efficiency means a better outcome

    Time frame: Everyday through intervention completion (from week 1 up to 16 weeks later)

Other outcomes

  1. Qualitative Interview

    A semi-structured interview with open-ended questions focusing on participants; experiences and change processes.

    Time frame: Three measures. Up to two weeks before the intervention, up to two weeks after the first intervention, up to two weeks after the second intervention

07

Study locations

1 site
  • CPLU (clinique psychologique et logopédique de l université de Liège)
    Liège, 4000, Belgium
08

References and documents

Individual participant data

Plan to share: Yes — all IPD collected throughout the trial

Supporting information: Clinical study report

Time frame: Beginning after publication with no end date

Access criteria: meta-analysis and that must be approved by the investigator

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for Jun 2027, 32 months after the start.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 32 months is above that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2024
First posted
Oct 9, 2024
StartActual
Oct 21, 2024
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jun 30, 2027
Last update
Nov 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06633263
Collaborators
Centre Hospitalier Universitaire de Liege
Responsible party
Audrey Krings (Principal Investigator, University of Liege) — Principal investigator
First posted
Oct 9, 2024
Start date
Oct 21, 2024
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Nov 1, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion